Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06409949 · ClinicalTrials.gov registry record · NA
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
A NA study of Peripheral Arterial Disease, sponsored by University of Nebraska.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06409949: Recruiting NA study of Peripheral Arterial Disease, sponsored by University of Nebraska.
NCT06409949 is a NA study of Peripheral Arterial Disease that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 60 participants, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06409949, a NA study of Peripheral Arterial Disease, is actively recruiting participants, sponsored by University of Nebraska.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
In our research, we are delving into whether taking MitoQ for six months can improve the symptoms and function of people diagnosed with peripheral artery disease, especially those who suffer from leg pain while walking, known as intermittent claudication. We will be checking if MitoQ helps people with claudication walk better, be more active every day, feel better about their lives, and if it enhances the health of their leg muscles.
Primary Outcome
Evaluation of maximum walking distance on treadmill until participant chooses to stop due to pain in his legs.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Walking assessment
- OTHER QOL Survey
- DIAGNOSTIC_TEST Ankle pressure at rest and after stress
- DIAGNOSTIC_TEST Muscle Oxygen
- DIAGNOSTIC_TEST Serum MitoQ Level
Study Locations (1)
Nebraska
- VA Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT06409949 shows while recruiting
NCT06409949 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 5 interventions - of which Walking assessment is the first listed.
NCT06409949 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT06409949 about?
NCT06409949 is a clinical study titled "MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology". In our research, we are delving into whether taking MitoQ for six months can improve the symptoms and function of people diagnosed with peripheral artery disease, especially those who suffer from leg pain while walking, known as intermittent claudication. We will be checking if MitoQ helps people wi...
What is the current status of trial NCT06409949?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-06-01. Estimated completion is 2027-06.
What conditions does trial NCT06409949 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease.
What interventions are being tested in trial NCT06409949?
The interventions under investigation include: Walking assessment (DIAGNOSTIC_TEST), QOL Survey (OTHER), Ankle pressure at rest and after stress (DIAGNOSTIC_TEST), Muscle Oxygen (DIAGNOSTIC_TEST), Serum MitoQ Level (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06409949?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06409949 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06409949's enrollment target sits among peer trials
60 49th of 79 higher than 30 of 79 other Peripheral Arterial Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SELUTION4BTK Trial
RECRUITING · NA
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Assessment of the Utility of the Pantheris Small Vessel (SV) System
RECRUITING · NA
-
Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI